(Q39734481)

14 September 2017

1 reference

title

Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties (English)

1 reference

14 September 2017

J Bouma

1

1 reference

14 September 2017

J H Beijnen

series ordinal

2

1 reference

14 September 2017

A Bult

series ordinal

3

1 reference

14 September 2017

W J Underberg

series ordinal

4

1 reference

14 September 2017

language of work or name

1 reference

1 April 1986

1 reference

Pharmaceutisch weekblad. Scientific edition

14 September 2017

1 reference

14 September 2017

8

1 reference

14 September 2017

109-133

1 reference

14 September 2017

2

1 reference

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion

14 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FBF02086146

Pharmacological and therapeutic efficacy of rubidazone in mice. Comparison with daunomycin and adriamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02086146

Interaction of new anthracycline antibiotics with DNA. Effects on nucleic acid synthesis and binding to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02086146

Physicochemical studies of the iron(III)-carminomycin complex and evidence of the lack of stimulated superoxide production by NADH dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02086146

Quelamycin, a new derivative of adriamycin with several possible therapeutic advantages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02086146

Possible intermediates in the action of adriamycin--a pulse radiolysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02086146

Effect of cell density on intracellular adriamycin concentration and cytotoxicity in exponential and plateau phase EMT6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02086146

Different distribution of adriamycin in normal and leukaemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02086146

Determination of adriamycin and its fluorescent metabolites in biological fluids of inpatients with lung cancer by high performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02086146

Predictive testing in cancer chemotherapy. II. In vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02086146

Comportement Polarographique d'Un Nouvel Agent Cytostatique: La Carminomycine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02086146

Tissue distribution and antitumor effect of liposome-entrapped doxorubicin (adriamycin) in Ehrlich solid tumor-bearing mouse

21 January 2018

1 reference

12 December 2020

Free radical damage to deoxyribose by anthracycline, aureolic acid and aminoquinone antitumour antibiotics. An essential requirement for iron, semiquinones and hydrogen peroxide

1 reference

12 December 2020

Relationship between effects on nucleic acid synthesis in cell cultures and cytotoxicity of 4-demethoxy derivatives of daunorubicin and adriamycin

1 reference

12 December 2020

Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity

1 reference

12 December 2020

Comparative cytotoxicities of various morpholinyl anthracyclines.

1 reference

12 December 2020

Photolytic Destruction of Adriamycin

1 reference

12 December 2020

Effect of route administration and liposome entrapment on the metabolism and disposition of adriamycin in the rat

1 reference

12 December 2020

Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 4'-epiadriamycin in mice

1 reference

12 December 2020

Comparison of Biochemical and Biological Methods in the Evaluation of New Anthracycline Drugs

1 reference

12 December 2020

Drug level monitoring: cytostatics

1 reference

12 December 2020

Liquid chromatographic determination of daunorubicin and daunorubicinol in plasma from leukemic patients

1 reference

12 December 2020

Antitumor anthracyclines: Recent developments

1 reference

12 December 2020

Quantitation of Daunorubicin, Doxorubicin, and Their Aglycones by Ion-pair Reversed-Phase Chromatography

1 reference

12 December 2020

Assay of doxorubicin and 4'-epidoxorubicin by reversed-phase ion-pair chromatography

1 reference

12 December 2020

Identification of new metabolites of daunomycin and adriamycin

1 reference

12 December 2020

Alterations in adriamycin efficacy by phenobarbital

1 reference

12 December 2020

Role of one-electron and two-electron reduction products of adriamycin and daunomycin in deoxyribonucleic acid binding

1 reference

12 December 2020

A double fluorescence method for determining doxorubicin distribution and vascular supply in the mouse kidney

1 reference

12 December 2020

1 reference

12 December 2020

Experience with the use of adriamycin in combination with other anticancer agents using a weekly schedule, with particular reference to lack of cardiac toxicity

1 reference

12 December 2020

Improved therapeutic benefits of doxorubicin by entrapment in anionic liposomes

1 reference

12 December 2020

Stability of doxorubicin in relation to chemosensitivity determinations: loss of lethality and retention of antiproliferative activity

1 reference

12 December 2020

Daunomycin and adriamycin metabolism via reductive glycosidic cleavage

1 reference

12 December 2020

Inhibition of oxidative phosphorylation in tumor cells and mitochondria by daunomycin and adriamycin

1 reference

12 December 2020

Differences in the pharmacokinetics of daunomycin in normal and leukemic rats.

1 reference

12 December 2020

High performance liquid chromatographic determination of aclacinomycin a and its related compounds. II. Reverse phase HPLC determination of aclacinomycin A and its metabolites in biological fluids using fluorescence detection

1 reference

12 December 2020

Pharmacokinetics of doxorubicin and its metabolite doxorubicinol in rabbits with induced acid and alkaline urine

1 reference

12 December 2020

Rapid analytic method for adriamycin and metabolites in human plasma by a thin-film fluorescence scanner

1 reference

12 December 2020

Bile secretory function: a determinant of adriamycin disposition

1 reference

12 December 2020

Stimulation by adriamycin of rat heart and liver microsomal NADPH-dependent lipid peroxidation

1 reference

12 December 2020

Initial biotransformations of daunorubicin to aglycones by rat liver microsomes

1 reference

12 December 2020

Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function

1 reference

12 December 2020

Effect of alpha-tocopherol on the cardiotoxicity of adriamycin in the rat

1 reference

12 December 2020

New antitumor antibiotics, aclacinomycins A and B

1 reference

12 December 2020

Interaction with protein SH groups could be involved in adriamycin cardiotoxicity

1 reference

12 December 2020

Mass spectrometry of some N-acyldaunosamine derivatives

1 reference

12 December 2020

One- and two-electron reduction of hydroxy-1,4-naphthoquinones and hydroxy-9,10-anthraquinones. The role of internal hydrogen bonding and its bearing on the redox chemistry of the anthracycline antitumour quinones

1 reference

12 December 2020

Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: geometry of intercalation of iremycin and daunomycin

1 reference

12 December 2020

The disposition of the new anthracycline antibiotic, menogarol, in mice

1 reference

12 December 2020

Self-association of doxorubicin and related compounds in aqueous solution

1 reference

12 December 2020

Interaction of some daunomycin derivatives with deoxyribonucleic acid and their biological activity

1 reference

12 December 2020

DNA binding studies on several new anthracycline antitumor antibiotics II. The importance of the carbomethoxy-group as position-10 of the class II anthracycline molecule

1 reference

12 December 2020

Daunorubicin metabolites in human urine

1 reference

12 December 2020

Spectrofluorophotometric determination of daunomycin in the tissues

1 reference

12 December 2020

OH•-generation by adriamycin semiquinone and H2O2; An explanation for the cardiotoxicity of anthracycline antibiotics

1 reference

12 December 2020

Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit

1 reference

12 December 2020

Auramycins and sulfurmycins, new anthracycline antibiotics: characterization of aglycones, auramycinone and sulfurmycinone

1 reference

12 December 2020

Disposition of 14C-labelled 4'-epidoxorubicin and doxorubicin in the rat. A comparative study

1 reference

12 December 2020

A method for the simultaneous measurement of the new anthracycline derivative 4'-deoxydoxorubicin and its metabolites by reversed phase liquid chromatography

1 reference

12 December 2020

Antitumor activity of esorubicin in human tumor clonogenic assay with comparisons to doxorubicin.

1 reference

12 December 2020

Adriamycin (14-hydroxydaunomycin), a novel antitumor antibiotic

1 reference

12 December 2020

Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex

1 reference

12 December 2020

Inhibition by the protein ceruloplasmin of lipid peroxidation stimulated by an Fe3+-ADP-adriamycin complex

1 reference

12 December 2020

Ethidium binding assay for reactive oxygen species generated from reductively activated adriamycin (doxorubicin)

1 reference

12 December 2020

Bacterial metabolism of daunomycin

1 reference

12 December 2020

Measurement of adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection

1 reference

12 December 2020

Antitumor agents from bohemic acid complex, III. The isolation of marcellomycin, musettamycin, rudolphomycin, mimimycin, collinemycin, alcindoromycin, and bohemamine

1 reference

12 December 2020

Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone

1 reference

12 December 2020

Mathematical model for adriamycin (Doxorubicin) pharmacokinetics

1 reference

12 December 2020

Recent studies on doxorubicin and its analogues

1 reference

12 December 2020

Adriamycin and daunorubicin disposition in the rabbit.

1 reference

12 December 2020

Determination of aclacinomycin A by reversed-phase high-performance liquid chromatography

1 reference

12 December 2020

Quantitation of anthracyclines in human hematopoietic cell subpopulations by flow cytometry correlated with high pressure liquid chromatography

1 reference

12 December 2020

New high-performance liquid chromatographic assay for plasma doxorubicin

1 reference

12 December 2020

Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations

1 reference

12 December 2020

Reverse phase high speed liquid chromatography of antibiotics. III. Use of ultra high performance columns and ion-pairing techniques

1 reference

12 December 2020

A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography

1 reference

12 December 2020

Letter: The structure of carminomycin I

1 reference

12 December 2020

Application of analytical and semi-preparative high-performance liquid chromatography to anthracyclines and bis-anthracycline derivatives

1 reference

12 December 2020

Cellular uptake and metabolism of daunorubicin as determined by high-performance liquid chromatography. Application to L1210 cells

1 reference

12 December 2020

Adriamycin (NSC-123,127): a new antibiotic with antitumor activity

1 reference

12 December 2020

Pharmacokinetics of 4'-epi-doxorubicin in man

1 reference

12 December 2020

Plasma concentrations of carminomycin and carminomycinol in man, measured by high pressure liquid chromatography

1 reference

12 December 2020

Interactions of heteroaromatic compounds with nucleic acids. 1. The influence of heteroatoms and polarizability on the base specificity of intercalating ligands

1 reference

12 December 2020

Rapid quantitative determination of seven anthracyclines and their hydroxy metabolites in body fluids

1 reference

12 December 2020

Clinical evaluation of long-term, continuous-infusion doxorubicin

1 reference

12 December 2020

American experience with carminomycin

1 reference

12 December 2020

Extraction and quantification of daunomycin and doxorubicin in tissues

1 reference

12 December 2020

Mechanism of action of the anthracycline anti-tumor antibiotics, doxorubicin, daunomycin and rubidazone: Preferential inhibition of DNA polymerase .ALPHA.

1 reference

12 December 2020

Reversed-phase liquid chromatography of adriamycin and daunorubicin and their hydroxyl metabolites adriamycinol and daunorubicinol

1 reference

12 December 2020

Adriamycin and metabolites: Separation by high-pressure liquid chromatography and quantitation by radioimmunoassay

1 reference

12 December 2020

Comparative studies on cardiotoxicity of some anthracycline antitumor antibiotics

1 reference

12 December 2020

Letter: A 13C nuclear magnetic resonance study of the biosynthesis of daunomycin from 13CH313CO2Na

1 reference

12 December 2020

Cellular pharmacokinetics of aclacinomycin A in cultured L1210 cells. Comparison with daunorubicin and doxorubicin

1 reference

12 December 2020

[Contribution to stability test of daunoblastin solutions (author's transl)]

1 reference

12 December 2020

Evaluation of new anthracycline analogs with the human tumor stem cell assay

1 reference

12 December 2020

Quantitative thin-layer chromatography: thin-film fluorescence scanning analysis of adriamycin and metabolites in tissue

1 reference

12 December 2020

Pharmacokinetic study on the mechanism of tissue distribution of doxorubicin: interorgan and interspecies variation of tissue-to-plasma partition coefficients in rats, rabbits, and guinea pigs.

1 reference

12 December 2020

Analysis of the pharmacokinetic characteristics, pharmacological and chemotherapeutic activity of 14-Hydroxy-daunomycin (Adriamycin), a new drug endowed with an antitumour activity

1 reference

12 December 2020

New anthracycline antibiotics

1 reference

12 December 2020

Improved high-performance liquid chromatography assay of doxorubicin: detection of circulating aglycones in human plasma and comparison with thin-layer chromatography

1 reference

12 December 2020

Liposomal protection of adriamycin-induced cardiotoxicity in mice

1 reference

12 December 2020

Pharmacokinetics and metabolism of adriamycin in man

1 reference

12 December 2020

Hepatobiliary metabolism and excretion of adriamycin and N-trifluoroacetyladriamycin-14-valerate in the rat

1 reference

12 December 2020

Sorbent removal of adriamycin in vitro and in vivo

1 reference

12 December 2020

The effect of physiological levels of divalent metal ions on the interaction of daunomycin with DNA: evidence of a ternary daunomycin-Cu2+-DNA complex

1 reference

12 December 2020

Cytophotometric analysis of the nuclear uptake of adriamycin in in vivo normal mouse liver and kidney cells

1 reference

12 December 2020

A Fickian diffusion transport process with features of transport catalysis. Doxorubicin transport in human red blood cells

1 reference

12 December 2020

Association of anthracycline derivatives with DNA: a fluorescence study

1 reference

12 December 2020

Microbial transformation of daunomycinone by Streptomyces aureofaciens B-96.

1 reference

12 December 2020

Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review

1 reference

12 December 2020

Lipid peroxidation and possible hydroxyl radical formation stimulated by the self-reduction of a doxorubicin-iron (III) complex

1 reference

12 December 2020

Determination of daunorubicin, doxorubicin and their fluorescent metabolites by high-pressure liquid chromatography: Plasma levels in DBA2 mice

1 reference

12 December 2020

Tissue distribution of adriamycin administered intraperitoneally vs. intravenously, with special emphasis on the pancreas

1 reference

12 December 2020

GLC--mass spectrometry of several important anticancer drugs II: doxorubicin and daunorubicin aglycone analogs

1 reference

12 December 2020

Murine metabolism and disposition of iron:adriamycin complexes

1 reference

12 December 2020

Metabolic disposition of 5-iminodaunorubicin in the rat.

1 reference

12 December 2020

Cardiotoxic effects of adriamycin and mitochondrial oxidation in rat cardiac tissue

1 reference

12 December 2020

Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes

1 reference

12 December 2020

Binding of adriamycin-Fe3+ complex to membrane phospholipids

1 reference

12 December 2020

Intensely potent morpholinyl anthracyclines

1 reference

12 December 2020

Further studies on the generation of reactive oxygen species from activated anthracyclines and the relationship to cytotoxic action and cardiotoxic effects

1 reference

12 December 2020

Cytotoxic efficacy of reconstituted and stored antitumor agents

1 reference

12 December 2020

Effect of divalent cations on the daunomycin-deoxyribonucleic acid complex

1 reference

12 December 2020

Determination of 4'-epidoxorubicin and its 13-dihydro derivative in human plasma by high-performance liquid chromatography with fluorescence detection

1 reference

12 December 2020

Absorption and circular dichroic spectral studies on the self-association of daunorubicin

1 reference

12 December 2020

Intraperitoneal infusion of doxorubicin in the treatment of gynecologic carcinomas

1 reference

12 December 2020

Biological activities of rubidazone

1 reference

12 December 2020

Determination of adriamycin (doxorubicin) and related fluorescent compounds in rat lymph and gall by high-performance liquid chromatography

1 reference

12 December 2020

Cell surface effects of adriamycin and carminomycin immobilized on cross-linked polyvinyl alcohol.

1 reference

12 December 2020

Liquid chromatography in anticancer drug research with special reference to anthraquinone glycosides

1 reference

12 December 2020

Phase I trial of 4-demethoxydaunorubicin with single i.v. doses

1 reference

12 December 2020

High-performance liquid chromatography and thin-layer chromatography of anthracycline antibiotics: separation and identification of components of the dauno-rubicin complex from fermentation broth

1 reference

12 December 2020

Evaluation of early doxorubicin-induced cardiotoxicity by means of systolic time intervals

1 reference

12 December 2020

Inhibition of liver metastases of M 5076 tumor by liposome-entrapped adriamycin

1 reference

12 December 2020

Phase I and clinical pharmacological evaluation of 4'-deoxydoxorubicin in patients with advanced cancer

1 reference

12 December 2020

Daunorubicin metabolism by human hematological components

1 reference

12 December 2020

Complex formation between purine and indole derivatives in aqueous solutions. Proton magnetic resonance studies

1 reference

12 December 2020

Laser flow cytometric studies on the intracellular fluorescence of anthracyclines

1 reference

12 December 2020

Experimental systemic toxicology of 4'-epidoxorubicin, a new, less cardiotoxic anthracycline antitumor agent

1 reference

12 December 2020

Self-association of daunomycin

1 reference

12 December 2020

Anthracycline assay by high-pressure liquid chromatography

1 reference

12 December 2020

Effects of adriamycin on supercoiled DNA and calf thymus nucleosomes studied with fluorescent probes.

1 reference

12 December 2020

Quantitative determination of low levels of daunomycin and daunomycinol in plasma by high-performance liquid chromatography

1 reference

12 December 2020

The total absolute configuration of daunomycin

1 reference

12 December 2020

Rapid analysis of doxorubicin in plasma by radial compression liquid chromatography

1 reference

12 December 2020

New developments on the mechanisms of action of antineoplastic drugs

1 reference

12 December 2020

Tissue distribution and disposition of daunomycin (NCS-82151) in mice: fluorometric and isotopic methods

1 reference

12 December 2020

Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity

1 reference

12 December 2020

Towards selectivity? Approaches to the design of new anti-tumour agents-II

1 reference

12 December 2020

Qualitative analysis of trimethylsilylated daunosamine and N-alkylated analogs by gas chromatography--mass spectrometry

1 reference

12 December 2020

Evaluation of vitamin E and selenium protection against chronic adriamycin toxicity in rabbits

1 reference

12 December 2020

Constant infusion schedule for adriamycin: a phase I-II clinical trial of a 30-day schedule by ambulatory pump delivery system

1 reference

12 December 2020

Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol

1 reference

12 December 2020

Reductive microbial conversion of anthracycline antibiotics

1 reference

12 December 2020

Adriamycin analogues. rationale, synthesis, and preliminary antitumor evaluation of highly active DNA-nonbinding N-(trifluoroacetyl)adriamycin 14-O-hemiester derivatives

1 reference

12 December 2020

Ultraviolet photoirradiation of daunomycin and DNA daunomycin complexes

1 reference

12 December 2020

Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy

1 reference

12 December 2020

Evidence of a specific complex between adriamycin and negatively-charged phospholipids.

1 reference

12 December 2020

Quantitative determination of adriamycin and daunorubicin-handling of blood and plasma samples

1 reference

12 December 2020

Mechanism of adriamycin cardiotoxicity: evidence for oxidative stress

1 reference

12 December 2020

Molecular structural effects involved in the interaction of anthracyclines with DNA

1 reference

12 December 2020

Protolytic equilibria of doxorubicin as determined by isoelectric focusing and 'electrophoretic titration curves'

1 reference

12 December 2020

High-performance liquid chromatographic method for pharmacokinetic studies on the new anthracycline 4-demethoxydaunorubicin and its 13-dihydro derivative

1 reference

12 December 2020

Daunorubicinol, a major metabolite of daunorubicin: isolation from human urine and enzymatic reactions

1 reference

12 December 2020

Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat

1 reference

12 December 2020

Doxorubicin cardiotoxicity in the rat: comparison of electrocardiogram, transmembrane potential, and structural effects.

1 reference

12 December 2020

Comparative pharmacokinetics of daunomycin and adriamycin in several animal species

1 reference

12 December 2020

Rapid determination of doxorubicin and its fluorescent metabolites by high pressure liquid chromatography

1 reference

12 December 2020

Antiheparin activity of Adriamycin

1 reference

12 December 2020

A new series of reductive amination derivatives of daunorubicin: syntheses, partition coefficients, and DNA binding

1 reference

12 December 2020

Extraction of daunorubicin and doxorubicin and their hydroxyl metabolites: self-association in aqueous solution

1 reference

12 December 2020

Diminished superoxide anion generation by reduced 5-iminodaunorubicin relative to daunorubicin and the relationship to cardiotoxicity of the anthracycline antitumor agents

1 reference

12 December 2020

Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice

1 reference

12 December 2020

Cellular pharmacodynamics of several anthracycline antibiotics

1 reference

12 December 2020

Self-association of daunorubicin

1 reference

12 December 2020

Quantitative thin-layer chromatographic measurement of n-trifluoroacetyladriamycin-14-valerate (AD 32) and trifluoroacetyladriamycin (AD 41) in blood and tissues

1 reference

12 December 2020

The structure of daunomycin

1 reference

12 December 2020

Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response

1 reference

12 December 2020

Electronic Absorption Spectra and Protolytic Equilibria of Doxorubicin: Direct Spectrophotometric Determination of Microconstants

1 reference

12 December 2020

A new antibiotic with antineoplastic activity: rubidomycin (13,057R.P.). L. Preparation and properties

1 reference

12 December 2020

Determination of the concentration of adriamycin and its metabolites in the serum and tissues of Ehrlich carcinoma-bearing mice by high-performance liquid chromatography

1 reference

12 December 2020

The anticancer agent adriamycin can be actively cytotoxic without entering cells

1 reference

12 December 2020

Properties of antitumor anthracyclines and new developments in their application: Cain memorial award lecture

1 reference

12 December 2020

New anthracycline antibiotics: serirubicin and 1-hydroxyserirubicin

1 reference

12 December 2020

Adriamycin and derivatives interaction with the mitochondrial membrane: O2 consumption and free radicals formation

1 reference

12 December 2020

Structure-activity relationships among daunorubicin and adriamycin analogs

1 reference

12 December 2020

Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moiety

1 reference

12 December 2020

Adriamycin metabolism in man. Evidence from urinary metabolites

1 reference

12 December 2020

New anthracycline derivatives from betaclamycin A

1 reference

12 December 2020

Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and effects of reactive oxygen scavengers

1 reference

12 December 2020

Akrobomycin, a new anthracycline antibiotic

1 reference

12 December 2020

Stability of anthracycline antitumour agents in infusion fluids

1 reference

12 December 2020

Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia

1 reference

12 December 2020

Reduction of O2 by iron-adriamycin

1 reference

12 December 2020

Pharmacokinetics of adriamycin in patients with breast cancer: correlation between pharmacokinetic parameters and clinical short-term response.

1 reference

12 December 2020

The effects of α-tocopherol on the toxicity, disposition, and metabolism of adriamycin in mice

1 reference

12 December 2020

Analysis of heterogeneity in daunorubicin uptake by human leukemia cells using laser flow cytometry

1 reference

12 December 2020

Antitumor anthracycline antibiotics, aclacinomycin A and analogues. II. Structural determination

1 reference

12 December 2020

Distribution of adriamycin in cancer patients: tissue uptakes, plasma concentration after IV and hepatic IA administration

1 reference

12 December 2020

Separation, characterization, and analysis of epirubicin (4'-epidoxorubicin) and its metabolites from human urine

1 reference

12 December 2020

The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review

1 reference

12 December 2020

Simplified toxicologic monitoring of adriamycin, its major metabolites and nogalamycin by reverse-phase high pressure liquid chromatography, Part I: Analytical techniques for isolated human plasma

1 reference

12 December 2020

Absence of generation of oxygen-containing free radicals with 4′-deoxydoxorubicin, a non-cardiotoxic anthracycline drug

1 reference

12 December 2020

GLC--mass spectrometry of several important anticancer drugs I: pertrimethylsilylation and O-methoxime formation

1 reference

12 December 2020

Mechanism of inhibition of DNA polymerases by 4'-epiadriamycin and 4'-O-tetrahydropyranyladriamycin

1 reference

12 December 2020

Experimental evaluation of anthracycline analogs

1 reference

12 December 2020

An extended conformational analysis of doxorubicin

1 reference

12 December 2020

Dissociation of antitumor potency from anthracycline cardiotoxicity in a doxorubicin analog.

1 reference

12 December 2020

Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopecia

1 reference

12 December 2020

A proton magnetic resonance study of the aggregation of actinomycin D in D 2 O.

1 reference

12 December 2020

Sensitive and specific determination of the new anthracycline analog 4'-epidoxorubicin and its metabolites by high pressure liquid chromatography

1 reference

12 December 2020

Stability of refrigerated and frozen solutions of doxorubicin hydrochloride

1 reference

12 December 2020

Stability and compatibility of antitumor agents in glass and plastic containers

1 reference

12 December 2020

Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral doses

1 reference

12 December 2020

Analysis of carminomycin in human serum by fluorometric high-performance liquid chromatography

1 reference

12 December 2020

Generation of hydroxyl radicals during the enzymatic reductions of the Fe3+-ADP-phosphate-adriamycin and Fe3+-ADP-EDTA systems. Less involvement of hydroxyl radical and a great importance of proposed perferryl ion complexes in lipid peroxidation

1 reference

12 December 2020

Rapid high-performance liquid chromatographic assay for the anthracyclines daunorubicin and 7-con-O-methylnogarol in plasma

1 reference

12 December 2020

[The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)]

1 reference

12 December 2020

Daunorubicin biliary excretion and metabolism in the rat

1 reference

12 December 2020

The effect of surfactants on the high-performance liquid chromatography of anthracyclines

1 reference

12 December 2020

Determination of adriamycin and daunorubicin in urine by high-performance liquid chromatography with laser fluorometric detection

1 reference

12 December 2020

Tissue distribution of doxorubicin and doxorubicinol in rats receiving multiple doses of doxorubicin

1 reference

12 December 2020

Pharmacokinetic analysis of adriamycin (doxorubicin) and related fluorescent compounds in Ehrlich tumor-bearing mouse plasma and tissues

1 reference

12 December 2020

Cellular Pharmacokinetics of Doxorubicin in Cultured Mouse Sarcoma Cells Originating from Autochthonous Tumors

1 reference

12 December 2020

Mass spectrometry of N-acylated daunorubicin derivatives

1 reference

12 December 2020

Hydroxyl radical production and DNA damage induced by anthracycline-iron complex

1 reference

12 December 2020

Biliary and urinary excretion of adriamycin in anesthetized rats.

1 reference

12 December 2020

Oxidative destruction of DNA by the adriamycin-iron complex.

1 reference

12 December 2020

Differential adriamycin distribution to blood components

1 reference

12 December 2020

Influence of tumor on adriamycin concentration in blood cells

1 reference

12 December 2020

Physical and chemical characteristics and structure of carminomycin, a new antitumor antibiotic

1 reference

12 December 2020

A high performance liquid chromatographic method of analysis of 4'-O-tetrahydropyranyladriamycin and their metabolites in biological samples

1 reference

12 December 2020

Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin

1 reference

12 December 2020

Structure of nogalamycin

1 reference

12 December 2020

Metabolism of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells

1 reference

12 December 2020

Structure-activity relation of daunorubicin and its peptide derivatives

1 reference

12 December 2020

Photolytic degradation of adriamycin

1 reference

12 December 2020

On the interaction of adriamycin with DNA: investigation of spectral changes

1 reference

12 December 2020

Continuous extraction of urinary anthracycline antitumor antibiotics with the horizontal flow-through coil planet centrifuge

1 reference

12 December 2020

Experimental evidence of characteristic tissue distribution of adriamycin. Tissue DNA concentration as a determinant

1 reference

12 December 2020

Decomposition of mitomycin and anthracycline cytostatics in cell culture media.

1 reference

12 December 2020

Phase 1 trial and assay of rubidazone (NSC 164011) in patients with advanced solid tumors

1 reference

12 December 2020

Direct in vitro photoaffinity labeling of DNA with daunorubicin, adriamycin, and rubidazone

1 reference

12 December 2020

Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogs

1 reference

12 December 2020

Electrochemical determination of adriamycin compounds in urine by preconcentration at carbon paste electrodes

1 reference

12 December 2020

Aspects of the chemical stability of doxorubicin and seven other anthracyclines in acidic solution

1 reference

12 December 2020

Determination of adriamycin, adriamycinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatography

1 reference

12 December 2020

Time dependency of adriamycin and adriamycinol kinetics

1 reference

12 December 2020

Anthracycline antibiotic pharmacology and metabolism

1 reference

12 December 2020

Comparative metabolism and excretion of adriamycin in man, monkey, and rat

1 reference

12 December 2020

Iron(III)-adriamycin and Iron(III)-daunorubicin complexes: physicochemical characteristics, interaction with DNA, and antitumor activity

1 reference

12 December 2020

Stability of anthracycline antitumor agents in four infusion fluids

1 reference

12 December 2020

Doxorubicin: alteration of dose scheduling as a means of reducing cardiotoxicity

1 reference

12 December 2020

Analysis of adriamycin and adriamycinol in micro volumes of rat plasma

1 reference

12 December 2020

Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography

1 reference

12 December 2020

3 The Molecular Basis for the Action of Some DNA-Binding Drugs

1 reference

12 December 2020

Aclarubicin: experimental and clinical experience

1 reference

12 December 2020

Fluorescence assays and pharmacokinetic studies of 4′-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors

1 reference

12 December 2020

Relationship between activity and amino sugar stereochemistry of daunorubicin and adriamycin derivatives

1 reference

12 December 2020

Plasma adriamycin and daunorubicin levels by fluorescence and radioimmunoassay

1 reference

12 December 2020

Mechanism of phospholipid peroxidation induced by ferric ion-ADP-adriamycin-co-ordination complex

1 reference

12 December 2020

Prevention of adriamycin toxicity

1 reference

12 December 2020

Uptake and distribution of daunorubicin and daunorubicin-DNA complex in mice as studied by whole-body autoradiography and liquid chromatography

1 reference

12 December 2020

Free radical formation from anthracycline antitumour agents and model systems--I. Model naphthoquinones and anthraquinones

1 reference

12 December 2020

The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation.

1 reference

12 December 2020

Distribution and metabolism of rubidazone and daunorubicin in mice

1 reference

12 December 2020

A fluorometric determination of adriamycin and its metabolites in biological tissues.

1 reference

12 December 2020

Biotransformations of daunorubicin aglycones by rat liver microsomes.

1 reference

12 December 2020

Uptake, metabolism, and cytotoxicity of doxorubicin in human Ewing's sarcoma and rhabdomyosarcoma cells

1 reference

12 December 2020

The solution spectroscopy of drugs and the drug-nucleic acid interactions

1 reference

12 December 2020

Fourier transform infrared spectra of cells treated with the drug adriamycin.

1 reference

12 December 2020

Pharmacokinetics of anthracyclines in dogs: evidence for structure-related body distribution and reduction to their hydroxy metabolites

1 reference

12 December 2020

Determination of doxorubicin hydrochloride in pharmaceutical preparations using high-pressure liquid chromatography

1 reference

12 December 2020

Antileukemic activity of 4-demethoxydaunorubicin in mice

1 reference

12 December 2020

Interaction of copper(II) ions with the daunomycin-calf thymus deoxyribonucleic acid complex

1 reference

12 December 2020

5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline

1 reference

12 December 2020

Quantitation of daunorubicin and its metabolites by high-performance liquid chromatography with electrochemical detection

1 reference

12 December 2020

Metabolism of 4'-modified analogs of doxorubicin. unique glucuronidation pathway for 4'-epidoxorubicin

1 reference

12 December 2020

Quantitation of anthracycline antitumor agent menogarol in plasma using liquid chromatography with fluorescence detection

1 reference

12 December 2020

ON PHYSICO-CHEMICAL INTERACTIONS BETWEEN DAUNOMYCIN AND NUCLEIC ACIDS

1 reference

12 December 2020

Quantitation of adriamycin in plasma and urine: comparative study of radioimmunoassay and high-performance liquid chromatography methods

1 reference

12 December 2020

Pharmacokinetic studies of 4'-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases

1 reference

12 December 2020

Chemical and biological stability of anticancer drugs used in a human tumor clonogenic assay.

1 reference

12 December 2020

Clinical pharmacology of daunorubicin in phase I patients with solid tumors: development of an analytical methodology for daunorubicin and its metabolites

1 reference

12 December 2020

HPLC determination of daunorubicin and daunorubicinol in human plasma

1 reference

12 December 2020

High performance liquid chromatographic determination of aclacinomycin A and its related compounds. I. Normal phase HPLC for monitoring fermentation and purification processes

1 reference

12 December 2020

Adriamycin: amelioration of toxicity by alpha-tocopherol

1 reference

12 December 2020

Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation

1 reference

12 December 2020

Cellular transport of anthracyclines by passive diffusion. Implications for drug resistance.

1 reference

12 December 2020

Disposition and metabolism of adriamycin in the rat.

1 reference

12 December 2020

Concomitant adsorption and stability of some anthracycline antibiotics

1 reference

12 December 2020

Cosmomycin D. A new anthracycline antibiotic.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1271/BBB1961.49.259

The structures of anthracycline antibiotics, cosmomycins A and B.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1271/BBB1961.49.1207

Identifiers

DOI

10.1007/BF02086146

1 reference

release_n3uejmi4grhkfcsot4s6ez764i

14 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/n3uejmi4grhkfcsot4s6ez764i

24 November 2022

mapped directly with Wikidata item

1 reference